Pacific Biosciences

PACB

Börsenwert 572 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
126	126 Vanguard Personalized Indexing Management Oakland, California	42.276 $	-1.370 $	-942	-4 %
127	127 Private Wealth Partners Mill Valley, California	42.000 $	–	–	–
128	128 Axxcess Wealth Management Carlsbad, California	40.609 $	-6.434 $	-4.425	-15 %
129	129 Cresset Asset Management Chicago, Illinois	39.493 $	–	–	–
130	130 Ameritas Investment Partners Lincoln, Nebraska	38.462 $	–	–	–
131	SCM 131 SVB Capital Management Menlo Park, California	34.584 $	–	–	–
132	132 Principal Financial Group Des Moines, Iowa	34.576 $	+12.479 $	+8.583	+72 %
133	133 Brighton Jones LLC Seattle, Washington	34.425 $	+9.429 $	+6.485	+46 %
134	134 Neuberger Berman Group New York	34.022 $	-15.542 $	-10.690	-35 %
135	135 Prime Capital Investment Advisors Overland Park, Kansas	33.471 $	-518 $	-356	-2 %
136	136 Bay Colony Advisors Concord, Massachusetts	31.920 $	-4.362 $	-3.000	-14 %
137	137 IFP Advisors Tampa, Florida	31.263 $	-23.403 $	-16.097	-46 %
138	138 Insigneo Advisory Services Miami, Florida	31.240 $	–	–	–
139	139 Bronte Capital Management Bondi Junction, Australia	30.040 $	+25.997 $	+17.881	Neu
140	140 Arax Advisory Partners Denver, Colorado	29.862 $	+22.742 $	+15.642	+733 %
141	141 Corient Private Wealth Miami, Florida	29.671 $	+1.166 $	+802	+5 %
142	142 Private Advisor Group Morristown, New Jersey	28.958 $	-10.904 $	-7.500	-30 %
143	143 ExodusPoint Capital Management New York	28.567 $	+24.722 $	+17.004	Neu
144	144 CIBC Bancorp USA Chicago, Illinois	27.204 $	+2.441 $	+1.679	+12 %
145	145 Quantinno Capital Management New York	25.827 $	+1.044 $	+718	+5 %
146	AHL 146 Abel Hall LLC Baton Rouge, Louisiana	25.138 $	-11.247 $	-7.736	-34 %
147	147 Ballentine Partners Waltham, Massachusetts	24.168 $	-3.311 $	-2.277	-14 %
148	148 Farallon Capital Management San Francisco, California	23.856 $	-175.631 $	-120.800	-89 %
149	149 Mirae Asset Global Investments Seoul, South Korea	23.337 $	-2.706 $	-1.861	-12 %
150	150 Tower Research Capital (TRC) New York	23.157 $	-53.406 $	-36.733	-73 %

Pacific Biosciences PACB Börsenwert 572 Mio. $

Pacific Biosciences

PACB

Börsenwert 572 Mio. $